Document Detail


Could local deliver of bisphosphonates be a new therapeutic choice for Gorham-Stout syndrome?
MedLine Citation:
PMID:  21044823     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The Gorham-Stout Syndrome is a rare condition in which spontaneous, progressive resorption of bone occurs. Even though the prognosis of the condition is generally considered to be good, Gorham-Stout syndrome can cause severe debilitation. In approximately 13% of recorded cases, death ensues. The treatment modalities for Gorham-Stout Syndrome include surgery, radiation therapy, anti-osteoclastic medications, however there is no known successful treatment. To date, the etiology of Gorham-Stout Syndrome is still controversial. However, general consensus on the importance of the derangement of osteoclastic activity and angiomatosis of blood vessels. Thus, local deliver of anti-osteoclastic and anti-angiogenic agents may be of great interest for the treatment of Gorham-Stout Syndrome. Bisphosphonates are potent in inhibiting osteoclast activity and promoting apoptosis, which has been widely used for the treatment of osteoporosis and osteolysis diseases and proved to be able to decrease the speed of bone destruction in Gorham-Stout Syndrome through systemic administration. In addition to its anti-osteolytic effect, bisphosphonates are currently shown to be capable of anti-angiogenesis and induction of apoptosis in tumor cells. Furthermore biocompatible calcium phosphate which is widely used for bone reconstruction in clinical has also been reported to be a suitable carrier for loading and releasing of bioactive bisphosphonates. Therefore, we hypothesis that local deliver of bisphosphonates by calcium phosphate may be a potential treatment of Gorham-Stout Syndrome.
Authors:
Siguo Sun; Xi Liu; Baoan Ma; Yong Zhou; Honghui Sun
Related Documents :
4061763 - Rett syndrome: a significant proportion of girls affected by autistic behavior.
20402703 - Myelodysplasia as a cause of hindlimb ataxia in two beef calves.
7151303 - Fronto-metaphyseal dysplasia. further delineation of the clinical syndrome.
Publication Detail:
Type:  Journal Article     Date:  2010-11-01
Journal Detail:
Title:  Medical hypotheses     Volume:  76     ISSN:  1532-2777     ISO Abbreviation:  Med. Hypotheses     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7505668     Medline TA:  Med Hypotheses     Country:  United States    
Other Details:
Languages:  eng     Pagination:  237-8     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Ltd. All rights reserved.
Affiliation:
Department of Orthopaedic Surgery, Tangdu Hospital, the Fourth Military Medical University, Xi'an, Shhanxi Province, 710038, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Down-regulation of O6-methylguanine-DNA methyl transferase enhances the effect of temozolomide in me...
Next Document:  Insect succession and carrion decomposition in selected forests of Central Europe. Part 3: Successio...